Top news of the week: 26.07.2022.
China approves Genuine Biotech's HIV drug for COVID patients
China on Monday gave conditional approval to domestic firm Genuine Biotech's Azvudine pill to treat certain adult patients with COVID-19, adding another oral treatment option against the ...
'Missile alert': Taiwan holds air-raid exercise amid China tension
Roads emptied and people were ordered to stay indoors in parts of Taiwan, including its capital Taipei, on Monday for an air-raid exercise as the island steps up preparations in the event ...
China plans 'great efforts' to consolidate economic recovery
China will make great efforts to consolidate its economic recovery particularly in the crucial third quarter, putting a priority on stabilising employment and prices, state media reported ...
China reports 1,012 new COVID cases for July 19 vs 776 day earlier
China reported 1,012 new coronavirus cases for July 19, of which 150 were symptomatic and 862 were asymptomatic, the National Health Commission said on Wednesday.
Japan health panel delays emergency approval of Shionogi COVID-19 pill
A Japanese health ministry panel on Wednesday delayed emergency approval for an oral treatment against COVID-19 that has been developed by Shionogi & Co .
Mainland China reports 817 new COVID cases for July 22 vs 1,011 day earlier
Mainland China reported 817 new COVID-19 cases for July 22, of which 164 were symptomatic and 653 were asymptomatic, the National Health Commission said on Saturday.
Akzo Nobel reports Q2 profit miss hit by China lockdowns, weaker Europe
Dutch paints and coatings maker Akzo Nobel reported on Wednesday weaker-than-expected quarterly core earnings, citing new coronavirus restrictions in China and slowing demand for decorative ...
China says medical insurance fund in the black, responding to concerns
China's national medical insurance fund ran a small surplus last year, a healthcare authority said on Saturday, a rare disclosure following public concern that the fund was losing money due ...